← Eichor
Condition: Fibroblast Activation Protein Inhibitor Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Fibroblast Activation Protein Inhibitor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3 · 15 location(s) · SOFIE · NCT07217717
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
NA · 1 location(s) · Jules Bordet Institute · NCT06107608
18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07077213
68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06277180
A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
Phase 2 · 1 location(s) · Mayo Clinic · NCT07083011
PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
Phase 1 · 1 location(s) · Karolinska University Hospital · NCT05172310
Unravelling Intestinal Fibrosis in Ulcerative Colitis
Phase 2/Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06604273
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06503146
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) P
Phase 3 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT07613099
Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)
Phase 2 · 1 location(s) · Institut Curie · NCT06659705
Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT07337850
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Phase 3 · 15 location(s) · SOFIE · NCT07217704
Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
NA · 1 location(s) · Jules Bordet Institute · NCT06061874
FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion
Phase N/A · 1 location(s) · Lin Zhao · NCT07020858
The Role of FAPI PET-CT in Diagnosing Endometriosis
NA · 1 location(s) · Ziv Hospital · NCT06792318
The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma
Phase 2/Phase 3 · 3 location(s) · Mara Veenstra, MD · NCT06355427
An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
EARLY_Phase 1 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT07132645
FAPI Imaging Assessment of Chronic Total Occlusion
Phase N/A · 2 location(s) · Lin Zhao · NCT06655922
68Ga-FAPI PET/CT in Malignant Tumors
NA · 1 location(s) · Zhongnan Hospital · NCT05034146
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.